An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of extended-release (ER)
paliperidone compared to aripiprazole (atypical antipsychotic) in symptomatic (having
symptoms) adolescent participants with schizophrenia (psychiatric disorder with symptoms of
emotional instability, detachment from reality, often with delusions and hallucinations
[imagining things], and withdrawal into the self) .